PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Biotechnology, Gautam Buddha University, Greater Noida, Uttar Pradesh, 201310, India.\', \'Department of Botany, Ch. Charan Singh University, Meerut, UP, 250004, India.\', \'Bioinformatics Laboratory, Uttarakhand Council for Biotechnology (UCB), Biotech Bhawan, Pantnagar, U.S. Nagar, Uttarakhand, 263145, India.\', \'Advanced Centre for Computational and Applied Biotechnology, Uttarakhand Council for Biotechnology (UCB), Dehradun, 248007, India.\', \'School of Biotechnology, Gautam Buddha University, Greater Noida, Uttar Pradesh, 201310, India. drvishwastripathi@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s43440-021-00228-0
?:doi
?:hasPublicationType
?:journal
  • Pharmacological reports : PR
is ?:pmid of
?:pmid
?:pmid
  • 33970450
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33970450>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33970450>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all